In patients with human epidermal growth factor 2 (HER2)-positive breast cancer, the MACC1 SNPs rs1990172, rs975263, and rs3735615 were associated with clinical outcome such as increased risk for progression or death and a significant protective impact on event-free survival and overall survival 24. Here, ERBB2 is linked to breast carcinoma.